BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value
$72.84+0.04 (+0.05%)
Close on Nov 12, 2026Market cap $11.44BP/E 66.8Yield 0.44%
Bio-Techne operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bio-Techne's operating cash flow for the twelve months ending Sep 30, 2026 was $337.60M, up 34.4% year over year. For fiscal 2026 it was $292.07M, up 1.6% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $352.16M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $292.07M | +1.6% |
| FY2025 | Jun 30, 2025 | $287.56M | -3.8% |
| FY2024 | Jun 30, 2024 | $298.98M | +17.5% |
| FY2023 | Jun 30, 2023 | $254.39M | -21.8% |
| FY2022 | Jun 30, 2022 | $325.27M | -7.6% |
| FY2021 | Jun 30, 2021 | $352.16M | +71.6% |
| FY2020 | Jun 30, 2020 | $205.22M | +13.0% |
| FY2019 | Jun 30, 2019 | $181.62M | +6.6% |
| FY2018 | Jun 30, 2018 | $170.37M | +18.5% |
| FY2017 | Jun 30, 2017 | $143.72M | -0.3% |
| FY2016 | Jun 30, 2016 | $144.16M | +3.4% |
| FY2015 | Jun 30, 2015 | $139.36M | +1.9% |
| FY2014 | Jun 30, 2014 | $136.76M | +10.7% |
| FY2013 | Jun 30, 2013 | $123.56M | -2.5% |
| FY2012 | Jun 30, 2012 | $126.75M | -0.4% |
| FY2011 | Jun 30, 2011 | $127.19M | +14.3% |
| FY2010 | Jun 30, 2010 | $111.26M | -0.1% |
| FY2009 | Jun 30, 2009 | $111.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $73.11M | +165.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $95.42M | -2.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $86.66M | +110.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $82.41M | -2.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $27.59M | -56.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $98.20M | +30.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $41.12M | -49.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $84.35M | +1.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $63.89M | +7.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $75.50M | -9.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $80.99M | +60.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $83.12M | +29.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $59.38M | +5.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $83.39M | -18.8% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $50.54M | -30.9% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $64.38M | -36.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $56.08M | +15.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $102.72M | -15.8% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $73.13M | -2.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $100.99M | +13.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $48.43M | -26.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $122.02M | +172.4% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $74.87M | +51.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $89.27M | +26.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $66.01M | +62.8% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $44.79M | -19.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $49.47M | +24.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $70.42M | +51.2% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $40.54M | +2.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $55.95M | -13.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $39.66M | +83.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $46.56M | +18.8% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $39.45M | -11.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $64.84M | +27.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $21.65M | -13.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $39.18M | -5.2% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $44.70M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $50.85M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $25.02M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $41.35M | – |
See a number that looks wrong?